2001 New Product Opportunities

• ReFacto® U.S. Launch

• PREVENAR® EU Approval and Launch

• PROTONIX® I.V. U.S. Approval and Launch

• RAPAMUNE® Liquid EU Approval and Launch

  • Recognizes Cyclosporine-sparing Effects of RAPAMUNE

• Totelle™ (17?-Estradiol/Trimegestone) Approvals Through European Mutual Recognition Procedure

• FluMist® U.S. Approval and Launch

• BMP-2 Long Bone Fracture U.S. Approval and Spinal Fusion Surgery U.S. Filing

Previous slide

Next slide

Back to first slide

View graphic version